NCT00451932View on ClinicalTrials.gov

A Study to Evaluate the Safety and Effectiveness of FK778 in Liver Transplant Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

303

Participants

Timeline

Start Date

October 31, 2002

Primary Completion Date

September 30, 2005

Study Completion Date

September 30, 2005

Conditions
Liver Transplantation
Interventions
DRUG

FK778

Trial Locations (29)

Unknown

Innsbruck

Brussels

Leuven

Edmonton

London

Toronto

Brno

Prague

Clichy

Lyon

Montpellier

Rennes

Strasbourg

Villejuif

Berlin

Essen

Hamburg

Hanover

Budapest

Milan

Udine

Rotterdam

Barakaldo

Barcelona

Madrid

Santiago de Compostela

Zurich

Birmingham

London

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY